Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Laurie H Sehn, MD MPH, Edward L G Hardy, MD FRCPC, Karamjit K Gill, MD FRCPC, Abdulwahab J Al-Tourah, MBChB, FRCPC, Jesse Shustik, MD, Nicol A Macpherson, MDPhDFRCPC,, Adrian Yee, MD FRCPC, Wendy Lam, MD, Kerry J. Savage, MD MSc, Richard Klasa, MD CM, FRCP(C), Diego Villa, MDMPH, Alina S Gerrie, MD, Tamara Shenkier, MD, Graham W Slack, MD, Randy D. Gascoyne, MD, Francois Benard, MD, Don Wilson, MD, Peter Tonseth, MD, Joseph M Connors, MD

Blood (2014) 124 (21): 392.

https://doi.org/10.1182/blood.V124.21.392.392

Published: 2014

Journal Articles

Tumor-Associated Macrophages Predict Outcome in Follicular Lymphoma

Robert Kridel, MD, King Tan, MBBS, Abdulwahab J. Al-Tourah, MD, Alden A. Moccia, MD, David W. Scott, MBChB PhD, Graham W. Slack, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD, Christian Steidl, MD, Randy D. Gascoyne, MD

Blood (2012) 120 (21): 682.

https://doi.org/10.1182/blood.V120.21.682.682

Published: 2012

Journal Articles

Sunitinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: Results of a Phase II Multi-Center Study of the NCIC Clinical Trials Group.

Rena Buckstein, MD, John Kuruvilla, MD, Neil Chua, MD, Christina Lee, David A Macdonald, MD, Abdulwahab J. Al-Tourah, MD, Alison Foo, Wendy Walsh, S. Percy Ivy, MD, Michael Crump, MD, Elizabeth Eisenhauer, MD

Blood (2009) 114 (22): 2729.

https://doi.org/10.1182/blood.V114.22.2729.2729

Published: 2009

Journal Articles

Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances

K.-John J. Cheung, Sohrab P. Shah, Christian Steidl, Nathalie Johnson, Thomas Relander, Adele Telenius, Betty Lai, Kevin P. Murphy, Wan Lam, Abdulwahab J. Al-Tourah, Joseph M. Connors, Raymond T. Ng, Randy D. Gascoyne, Douglas E. Horsman

Blood (2009) 113 (1): 137–148.

https://doi.org/10.1182/blood-2008-02-140616

Published: 2009

Includes: Supplemental data

Journal Articles

Addition of Rituximab to CHOP Chemotherapy Significantly Improves Survival of Patients with Transformed Lymphoma.

Abdulwahab J. Al-Tourah, MB BCh, FRCPC, Kerry J. Savage, MD, MPH, FRCPC, Karamjit K. Gill, MD, FRCPC, Richard J. Klasa, MD, FRCPC, Laurie H. Sehn, MD, FRCPC, Tamara N. Shenkier, ND, FRCPC, Randy D. Gascoyne, MD, FRCPC, Joseph M. Connors, MD, FRCPC

Blood (2007) 110 (11): 790.

https://doi.org/10.1182/blood.V110.11.790.790

Published: 2007

Journal Articles

Myeloablative Allogeneic Stem Cell Transplantation for Relapsed Composite Low and Intermediate Grade Lymphoma Is Not Superior to Autologous Stem Cell Transplantation - Reduced Relapse Risk Is Offset by Higher Treatment Related Mortality.

Khaled M. Ramadan, Joseph M. Connors, Abdulwahab J. Al-Tourah, Randy D. Gascoyne, Kevin Song, Michael J. Barnett, Stephen H. Nantel, Thomas J. Nevill, John D. Shepherd, Heather J. Sutherland, Julye Lavoie, Donna L. Forrest, Donna E. Hogge, Nicholas J. Voss, Clayton A. Smith, Cynthia L. Toze

Blood (2006) 108 (11): 3039.

https://doi.org/10.1182/blood.V108.11.3039.3039

Published: 2006

Journal Articles

Prior Rituximab Reduces Relapse and Improves Survival Following High Dose Chemotherapy and Stem Cell Transplantation for Relapsed Composite Low and Intermediate Grade (Including Transformed) Lymphoma.

Blood (2006) 108 (11): 3662.

https://doi.org/10.1182/blood.V108.11.3662.3662

Published: 2006

Journal Articles

Transformed Lymphoma: Incidence and Long-Term Outcome.

Abdulwahab J. Al-Tourah, MB, BCh, FRCPC, Mukesh Chhanabhai, MD, FRCPC, Paul J. Hoskins, MD, FRCPC, Richard J. Klasa, MD, FRCPC, Kerry J. Savage, MD, FRCPC, Laruie H. Sehn, MD, FRCPC, Tamara N. Shenkier, MD, FRCPC, Randy D. Gascoyne, MD, FRCPC, Joseph M. Connors, MD, FRCPC

Blood (2004) 104 (11): 3253.

https://doi.org/10.1182/blood.V104.11.3253.3253

Published: 2004

NARROW

Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Tumor-Associated Macrophages Predict Outcome in Follicular Lymphoma

Sunitinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: Results of a Phase II Multi-Center Study of the NCIC Clinical Trials Group.

Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances

Addition of Rituximab to CHOP Chemotherapy Significantly Improves Survival of Patients with Transformed Lymphoma.

Myeloablative Allogeneic Stem Cell Transplantation for Relapsed Composite Low and Intermediate Grade Lymphoma Is Not Superior to Autologous Stem Cell Transplantation - Reduced Relapse Risk Is Offset by Higher Treatment Related Mortality.

Prior Rituximab Reduces Relapse and Improves Survival Following High Dose Chemotherapy and Stem Cell Transplantation for Relapsed Composite Low and Intermediate Grade (Including Transformed) Lymphoma.

Transformed Lymphoma: Incidence and Long-Term Outcome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only